1. Toll‑like receptor agonist rMBP‑NAP enhances antitumor cytokines production and CTL activity of peripheral blood mononuclear cells from patients with lung cancer
   Cong Ding et al, 2018, Oncology Letters CrossRef
2. Intercepting Premalignant, Preinvasive Breast Lesions Through Vaccination
   Nadia Nocera Zachariah et al, 2021, Frontiers in Immunology CrossRef
3. MUC1 and MUC16: critical for immune modulation in cancer therapeutics
   Xinyi Chen et al, 2024, Frontiers in Immunology CrossRef
4. A review on development of MUC1-based cancer vaccine
   Tong Gao et al, 2020, Biomedicine & Pharmacotherapy CrossRef
5. Recombinant MUC1-MBP fusion protein combined with CpG2006 vaccine induces antigen-specific CTL responses through cDC1-mediated cross-priming mainly regulated by type I IFN signaling in mice
   Yu Liu et al, 2022, Immunology Letters CrossRef
6. CpG ODN1826 as a Promising Mucin1-Maltose-Binding Protein Vaccine Adjuvant Induced DC Maturation and Enhanced Antitumor Immunity
   Jing Jie et al, 2018, International Journal of Molecular Sciences CrossRef
7. Immunological Evaluation of Recent MUC1 Glycopeptide Cancer Vaccines
   Md Hossain et al, 2016, Vaccines CrossRef
8. Optimizing the Expression and Solubilization of an E. coli-Produced Leukemia Inhibitory Factor for Anti-LIF Antibody Production and Use Thereof for Contraception in Mice
   Nahid Mehri et al, 2021, Molecular Biotechnology CrossRef
9. Designing a Multi-epitope Peptide Vaccine Against COVID-19 Variants Utilizing In-silico Tools
   Hassan Dariushnejad et al, 2021, Iranian Journal of Medical Microbiology CrossRef
10. Mycobacteria-Based Vaccines as Immunotherapy for Non-urological Cancers
    Estela Noguera-Ortega et al, 2020, Cancers CrossRef
11. Designing a Novel Multi-epitope T Vaccine for “Targeting Protein for Xklp-2” (TPX2) in Hepatocellular Carcinoma Based on Immunoinformatics Approach
    Parisa Ghahremanifard et al, 2020, International Journal of Peptide Research and Therapeutics CrossRef
12. Antitumor and immunomodulatory effects of recombinant fusion protein rMBP-NAP through TLR-2 dependent mechanism in tumor bearing mice
    Ting Wang et al, 2015, International Immunopharmacology CrossRef
13. Mycobacterium bovis BCG in metastatic melanoma therapy
    Martha Lucia Ruiz Benitez et al, 2019, Applied Microbiology and Biotechnology CrossRef
14. UCST-Type Soluble Immobilized Cellulase: A New Strategy for the Efficient Degradation and Improved Recycling Performance of Wastepaper Cellulose
    Zhaohui Chen et al, 2024, Molecules CrossRef
15. Mycolicibacterium brumae is a Safe and Non-Toxic Immunomodulatory Agent for Cancer Treatment
    Marc Bach-Griera et al, 2020, Vaccines CrossRef
16. Mucins as anti-cancer targets: perspectives of the glycobiologist
    Inka Brockhausen et al, 2021, Glycoconjugate Journal CrossRef
17. Pre-clinical toxicity and immunogenicity evaluation of a MUC1–MBP/BCG anti-tumor vaccine
    Boqi Hu et al, 2016, International Immunopharmacology CrossRef
18. Production of recombinant HPV11/16 E6/E7-MBP-His6 fusion proteins and their potential to induce cytokine secretion by immune cells in peripheral blood
    Mei-nian Xu et al, 2024, Virology Journal CrossRef